Under the glaring floodlights of N'djili International Airport in Kinshasa, ground crews wearing high-visibility vests stack heavy, insulated thermal shippers onto transport pallets. Inside these specialized containers, packed with dry ice, lie the first major consignments of the MVA-BN mpox vaccine destined for the frontlines of a growing public health emergency. This urgent logistical operation marks a critical turning point in the global health response to the highly virulent Clade Ib strain of the virus, which has rapidly swept through the Democratic Republic of the Congo (DRC) and crossed into neighboring East African nations. The deployment represents a high-stakes race against time to contain a pathogen that scientists warn is significantly more transmissible and lethal than the strain that caused the global outbreak in 2022. ...